Aerogen wins Medical Technology Company award for its innovative solutions to healthcare providers

Aerogen, a medical device and drug delivery company has been honoured as the Medical Technology Company of the Year Award 2013. Aerogen's patented vibrating mesh technology turns liquid medication into a fine particle mist, gently and effectively delivering drugs to the lungs of critically ill patients. The award is in recognition of Aerogen's strategic vision which has seen the company build and sustain global business growth by delivering innovative and cost-effective solutions to healthcare providers.

The award is a promoted by Irish Medical Device Association (IMDA), Enterprise Ireland and the IDA for the medical technology sector in Ireland and is aimed at promoting and recognising outstanding performance in quality of products and services, innovation and marketing, sales and business development, customer care and professional development of staff.

"It is a great honour for Aerogen to be recognised as the Medical Technology Company of the Year 2013. As an Irish owned company we are immensely proud of the fact that our life saving products is sold in over sixty countries around the world and that today Aerogen is a recognised global brand leader in acute-care aerosol drug delivery" John Power, CEO, Aerogen commented.

From Aerogen's MBO through to its repatriation of the manufacturing process the company has implemented strategies to drive global business growth from its Galway base. Through its high performance team the company has created a holistic approach to medical device business development encompassing sales, marketing, engineering, manufacturing and customer care. Aerogen will continue to grow and prosper and be an Irish Medical Device success story.

Aerogen's products are now used in Intensive Care Units in more than 60 countries around the globe, providing optimum care to the most critical patients from pre-term babies to adults. As the company continues to grow and prosper, the impact of Aerogen's success can be seen from the 1,000,000 patients who have benefited from the superior performance of Aerogen products.